Dexmedetomidine sedation leading to refractory cardiogenic shock.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 18499610.
- Also identified by DOI 10.1213/ane.0b013e318172fafc.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Dexmedetomidine is frequently used for deep sedation during electrophysiology procedures. We report a case where, presumably, the use of dexmedetomidine resulted in a patient's death. The patient developed unexplained and refractory cardiogenic shock and could not be resuscitated. Autopsy failed to demonstrate any abnormality or cause of death. We postulate that, in certain susceptible individuals, dexmedetomidine may lead to terminal complications. We therefore urge caution about using dexmedetomidine in the electrophysiology laboratory.
Medical subject headings
- Adrenergic alpha-Agonists
- Atrial Fibrillation
- Dexmedetomidine
- Electrophysiologic Techniques, Cardiac
- Hypnotics and Sedatives
- Shock, Cardiogenic